TRCT
PAND

Tower Research Capital (TRC)’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Tower Research Capital (TRC)’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-603
Closed -$36K – 6324
2021
Q1 		$36K Sell
603
-3,160
-84% -$114K ﹤0.01% 3412
2020
Q4 		$56K Buy
3,763
+2,267
+152% +$31.5K ﹤0.01% 3011
2020
Q3 		$17K Buy
+1,496
New +$25.6K ﹤0.01% 3922

Tower Research Capital (TRC)'s PAND Position: Q2 2021 in Review

Tower Research Capital (TRC) sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 603 shares — an estimated $36K sold.

Tower Research Capital (TRC) first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $56K in Q4 2020. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Tower Research Capital (TRC) reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 603 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $36K.
  • Tower Research Capital (TRC) first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s Pandion Therapeutics Inc. Common Stock position peaked at $56K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.